![Keith E. Dionne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith E. Dionne
Keine laufenden Positionen mehr
Profil
Keith E.
Dionne is the founder of Casma Therapeutics, Inc. Former positions include President & Chief Executive Officer at Alantos Pharmaceuticals Holding, Inc. from 2004 to 2011, President & Chief Executive Officer at Surface Logix LLC from 2008 to 2010, Chief Executive Officer at Alantos Pharmaceuticals AG, President, Chief Executive Officer & Director at Constellation Pharmaceuticals, Inc., Director at Pique Therapeutics, Inc., Principal at Millennium Pharmaceuticals, Inc., Entrepreneur-in-Residence at Third Rock Ventures LLC, and Head-Pre Clinical Research & Development at ALZA Pharmaceuticals.
Education includes graduate and doctorate degrees from the Massachusetts Institute of Technology.
Ehemalige bekannte Positionen von Keith E. Dionne
| Unternehmen | Position | Ende |
|---|---|---|
Surface Logix LLC
 Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Präsident | 31.12.2010 |
Casma Therapeutics, Inc.
 Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates MA-based biotechnology company harnessing natural cellular process of autophagy to design new medicines | Gründer | - |
| CONSTELLATION PHARMACEUTICALS, INC. | Vorstandsvorsitzender | - |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Corporate Officer/Principal | - |
ALZA Pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Keith E. Dionne
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Alantos Pharmaceuticals AG
 Alantos Pharmaceuticals AG BiotechnologyHealth Technology Develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
ALZA Pharmaceuticals | |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Pique Therapeutics, Inc.
 Pique Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic vaccines for the treatment of cancer | Health Technology |
Casma Therapeutics, Inc.
Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates MA-based biotechnology company harnessing natural cellular process of autophagy to design new medicines | Commercial Services |
